Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Center for Digital Health Innovation, University of California, San Francisco, San Francisco, CA, USA.
J Diabetes Sci Technol. 2022 May;16(3):596-604. doi: 10.1177/1932296820984490. Epub 2021 Jan 12.
With the first commercially available smart insulin pens, the predominant insulin delivery device for millions of people living with diabetes is now coming into the digital age. Smart insulin pens (SIPs) have the potential to reshape a connected diabetes care ecosystem for patients, providers, and health systems. Existing SIPs are enhanced with real-time wireless connectivity, digital dose capture, and integration with personalized dosing decision support. Automatic dose capture can promote effective retrospective review of insulin dose data, particularly when paired with glucose data. Patients, providers, and diabetes care teams will be able to make increasingly data-driven decisions and recommendations, in real time, during scheduled visits, and in a more continuous, asynchronous care model. As SIPs continue to progress along the path of digital transformation, we can expect additional benefits: iteratively improving software, machine learning, and advanced decision support. Both these technological advances, and future care delivery models with asynchronous interactions, will depend on easy, open, and continuous data exchange between the growing number of diabetes devices. SIPs have a key role in modernizing diabetes care for a large population of people living with diabetes.
随着首款商业化的智能胰岛素笔问世，数以百万计的糖尿病患者所使用的主要胰岛素给药装置现在正迈入数字时代。智能胰岛素笔（SIP）有可能重塑患者、医护人员和医疗系统的互联式糖尿病护理生态系统。现有的 SIP 通过实时无线连接、数字剂量记录以及与个性化剂量决策支持的整合而得到增强。自动剂量记录可促进对胰岛素剂量数据的有效回顾性审查，尤其是与血糖数据结合使用时。患者、医护人员和糖尿病护理团队将能够在预约就诊期间以及在更连续、非同步的护理模式中，实时做出更具数据驱动性的决策和建议。随着 SIP 沿着数字化转型的道路继续发展，我们可以期待更多的好处：软件、机器学习和高级决策支持的不断迭代改进。这些技术进步以及未来具有非同步交互的护理模式，将依赖于日益增多的糖尿病设备之间易于、开放和持续的数据交换。SIP 在为数以百万计的糖尿病患者实现糖尿病护理现代化方面发挥着关键作用。
